Sarecycline vs Doxycycline for Acne

This trial explores how two acne treatments, Sarecycline and Doxycycline, affect gut and skin bacteria. Researchers aim to determine if either treatment alters the types of bacteria in these areas. Participants will be divided into two groups, with some receiving Sarecycline and others receiving Doxycycline. Individuals with acne, having at least 10 inflamed pimples but no more than 2 large nodules on their face, may qualify for this study. As a Phase 4 trial, this research seeks to understand how these FDA-approved treatments benefit a broader range of patients.

Yes, you may need to stop certain medications before joining the trial. Specifically, you should not have used topical acne medications, benzoyl peroxide, or anti-inflammatories on your face within 2 weeks, systemic antibiotics or acne treatments within 4 weeks, or systemic retinoids within 12 weeks before starting the study.

Previous studies have shown that sarecycline is generally well-tolerated, with few side effects. Approximately 4.7% of patients experienced mild adverse reactions. The FDA has approved sarecycline for treating certain types of acne, indicating a good safety record.

Researchers are excited about sarecycline and doxycycline for acne because these treatments offer unique benefits compared to standard options like minocycline or tetracycline. Sarecycline is a next-generation tetracycline-derived antibiotic that is designed to specifically target acne-causing bacteria while minimizing side effects, such as gastrointestinal discomfort, which are common with other antibiotics. Doxycycline is a well-known antibiotic that not only targets bacteria but also reduces inflammation, making it a dual-action treatment option. Both treatments have the potential to enhance patient outcomes by providing more effective and tolerable options for managing acne.

This trial will compare the effectiveness of Sarecycline and Doxycycline for treating acne. Research has shown that both medications effectively treat acne. Participants in the Sarecycline Group will receive sarecycline, a newer medication that significantly reduces red, swollen acne spots and improves skin perception. Designed specifically for acne, sarecycline is taken once a day.